MIR3663HG

Across TCGA pan-cancer cohorts, MIR3663HG RNA is linked to patient survival in 10 of 34 cancer types, making it the most broadly survival-associated MIR3663HG data layer.

The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where higher MIR3663HG RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated MIR3663HG expression acts as an unfavorable survival marker.

UCEC, STAD, and KIRP are the cancer types where MIR3663HG RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UCEC	DFS	Tertile	All	0.508	0.658	.001	84	view →
STAD	OS	Tertile	III,IV	0.181	0.432	.004	46	view →
KIRP	OS	Tertile	All	0.650	0.951	.002	36	view →
PAAD	OS	Tertile	II,III,IV	0.146	0.557	<.001	36	view →
KIRC	OS	Tertile	All	0.802	0.879	.021	30	view →
COAD	OS	Tertile	II,III,IV	0.591	0.860	.010	18	view →
LIHC	DFS	Tertile	All	0.174	0.442	.020	18	view →
SARC	OS	Tertile	All	0.418	0.870	<.001	12	view →
SKCM	DFS	Tertile	IV	0.036	0.433	<.001	9	view →
LUSC	OS	Tertile	All	0.607	0.695	.030	6	view →

Pink = unfavorable, green = favorable. Showing the 10 strongest of 10 lineages.

MIR3663HG–UCEC (DFS)

Open the UCEC breakdown →